Klotho in acute kidney injury: biomarker, therapy, or a bit of both?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 21116272.
- Also identified by DOI 10.1038/ki.2010.367.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Acute kidney injury (AKI) diagnosis is based on an increase in serum creatinine or a decrease in urine output. To be effective, treatment of AKI should be started very early after the insult and well before the rise of serum creatinine. Thus, sensitive biologic markers of renal tubular injury in AKI are strongly needed. Hu et al. suggest that Klotho could be a novel biomarker and therapeutic target of ischemia-induced AKI.
Medical subject headings
- Acute Kidney Injury
- Glucuronidase
- Reperfusion Injury